Paul Tudor Jones Chroma Dex Corp. Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 371,798 shares of CDXC stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
371,798
Previous 217,568
70.89%
Holding current value
$2.28 Million
Previous $1.16 Million
122.08%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
158Shares Held
25.2MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...